Bladder Cancer Advocacy Network

Creating better todays and more tomorrows for bladder cancer patients and families since 2005.

[Bladder Cancer Advocacy Network @BladderCancerUS]

Bladder cancer is on of the most expensive cancers to treat. @cancer_nursing https://t.co/6qqcw3tZNq

[Bladder Cancer Advocacy Network @BladderCancerUS]

Reminder: Applications for the BCAN Continuity Grant are due June 29.

If your bladder cancer or UTUC research was impacted by federal funding cuts, or if your NIH-reviewed proposal was deemed fundable but not funded due to budget constraints, this opportunity was created for you.

Don't let promising research stall. Apply by 6/29.

[Bladder Cancer Advocacy Network @BladderCancerUS]

Watch @PGrivasMDPhD join Jonathan Wright, MD, MS, FACS for a discussion on bladder cancer risk factors, emerging research, multidisciplinary care, and the future of treatment.
https://t.co/OSyea8Ijgh

[Bladder Cancer Advocacy Network @BladderCancerUS]

@Yale_Urology @FedGhali @YaleMed Congrats, Dr. Ghali!

[UroToday.com @urotoday]

Findings from the bladder burden survey: Patient perspectives on communication, trust, and quality of life in #BladderCancer. Meri-Margaret Deoudes, CFRE @BladderCancerUS joins @UroDocAsh @UTMDAnderson to discuss findings from the Bladder Burden Survey. The survey identified delayed diagnosis in women, patient reluctance to discuss bladder cancer due to stigma, and mental health strain as persistent gaps, consistent with prior BCAN and World Bladder Cancer Patient Coalition surveys. #WatchNow > https://t.co/RNl6N8I0ma @WorldBladderCan

[Bladder Cancer Advocacy Network @BladderCancerUS]

Watch Deion Sanders on @GMA discuss "getting his swagger back" after his bladder cancer treatment last year: https://t.co/F41id5et2s

[Bladder Cancer Advocacy Network @BladderCancerUS]

@ERPlimackMD @siadaneshmand Learn more and register here: https://t.co/Kczg7WKnbU

[Bladder Cancer Advocacy Network @BladderCancerUS]

How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer?

Continuing education from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
@RedMedEd

[Bladder Cancer Advocacy Network @BladderCancerUS]

Learn about the BCAN Continuity Grant:https://t.co/Kkvxcrw7MF

[Bladder Cancer Advocacy Network @BladderCancerUS]

Important bladder cancer research should not be left behind.

BCAN's Continuity Grant provides support for U.S.-based bladder cancer and UTUC projects affected by federal funding cuts or NIH-reviewed, fundable proposals that missed funding due to budget limitations.

Learn more and apply by 6/29.

[UPMC Urology @UPMCUrology]

Last Saturday, we joined bladder cancer survivors, caregivers, families, and advocates at the Pittsburgh Walk to End Bladder Cancer. 🧡💙 

Thank you to everyone who joined our UPMC team in support of the bladder cancer community!

@BladderCancerUS #bladdercancerawareness

[KMittaloncMD @KMittalmd]

Grateful to serve as the invited speaker at this year’s @BladderCancerUS Walk in Boston and to represent @UMassCancer Cancer Research Office.
Through science, advocacy, and community, we continue the fight to improve outcomes for patients with bladder cancer. @UMass_Medicine

[Bladder Cancer Advocacy Network @BladderCancerUS]

We are pleased to welcome @divyaajay_uro of @MSKCancerCenter on June 25 at 4 PM ET for a webinar.

Dr. Ajay will share her expertise on urinary diversion options after bladder removal surgery, shared decision-making, and tools that help patients make informed treatment choices.

[Bladder Cancer Advocacy Network @BladderCancerUS]

Aspirin can cause mild bleeding or worsen existing bleeding in the urinary tract. This may prompt a clinician to run tests that uncover asymptomatic bladder tumors.

[JIM - Journal of Internal Medicine @JInternMed]

New article to read! Aspirin or non-steroidal anti-inflammatory drug initiation and subsequent bladder cancer evaluation.

🔗https://t.co/8PYAleDU7l

#aspirin #bladdercancer #cancer #earlydiagnosis #cystoscopy #NSAID #Uncover

[Rebecca Johnson @BCAN_Research]

Know a bladder cancer researcher whose federal funding was terminated - or who scored ≤8th percentile at NIH but wasn't funded?

BCAN's 2026 Continuity Grant is now open, awards up to $200K. https://t.co/wFMKDkfZxZ

⏰ Apply by June 29, please share widely!
@BladderCancerUS

[Max Kates @MaxKates]

Big congrats our BCAN Quale Fellows. And thank you to all the reviewers in this incredibly competitive application cycle We are fortunate to be in a golden age of bladder cancer progress. Thrilling to see that we are able to recruit such talent to the field.
@BladderCancerUS

[Bladder Cancer Advocacy Network @BladderCancerUS]

@VinceDAndreaMD We appreciate you participating! See you next month.

[Bladder Cancer Advocacy Network @BladderCancerUS]

Congratulations to the 2026 John Quale Travel Fellowship recipients! We are proud to support the next generation of bladder cancer researchers and clinicians as they join us at the 2026 Bladder Cancer Think Tank. Your dedication to advancing bladder cancer research will help shape the future of patient care. @UofCalifornia @MSKCancerCenter @WeillCornell @Yale @theNCI @UW @MoffittNews @UHhospitals

[UroToday.com @urotoday]

Patient experiences with UGN-102 for recurrent low-grade intermediate-risk #NMIBC: Insights for shared decision making. Presentation by @RuchikaTalwarMD @VUMChealth. #ASCO26 written coverage by @zklaassen_md @GACancerCenter > https://t.co/pdsCvXmbsE @ASCO

[UroToday.com @urotoday]

Outcomes with enfortumab vedotin rechallenge after disease progression in metastatic #UrothelialCarcinoma. Presentation by @MichalSternsch @MSKCancerCenter. #ASCO26 written coverage by @RKSayyid @UAUrology > https://t.co/e5JeF4ckvS @ASCO